Camallergy Revenue and Competitors
Estimated Revenue & Valuation
- Camallergy's estimated annual revenue is currently $1.8M per year.
- Camallergy's estimated revenue per employee is $102,000
Employee Data
- Camallergy has 18 Employees.
- Camallergy grew their employee count by -22% last year.
Camallergy's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder and Senior Medical Advisor | Reveal Email/Phone |
2 | Co-founder/Chief Medical Officer | Reveal Email/Phone |
3 | CFO - Consultant | Reveal Email/Phone |
4 | Operations Manager | Reveal Email/Phone |
5 | Research And Development Manager | Reveal Email/Phone |
6 | Senior Lab Analyst | Reveal Email/Phone |
7 | Co-Founder/COO | Reveal Email/Phone |
8 | Laboratory Analyst | Reveal Email/Phone |
9 | Laboratory Analyst | Reveal Email/Phone |
Camallergy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.8M | 43 | 5% | N/A | N/A |
#2 | $3.5M | 29 | 0% | N/A | N/A |
#3 | $0.5M | 6 | 0% | N/A | N/A |
#4 | $1.1M | 11 | 0% | N/A | N/A |
#5 | $1M | 10 | 0% | N/A | N/A |
#6 | $2.4M | 20 | 5% | N/A | N/A |
#7 | $1.5M | 15 | -29% | N/A | N/A |
#8 | $3.5M | 29 | -3% | N/A | N/A |
#9 | $31.4M | 168 | 25% | N/A | N/A |
#10 | $31.4M | 168 | 26% | N/A | N/A |
What Is Camallergy?
Millions of people suffer from food allergy. We develop pioneering treatments so they can live free from fear.
keywords:N/AN/A
Total Funding
18
Number of Employees
$1.8M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Camallergy News
2022-04-17 - Global Food Allergy Pipeline Market Insights Report 2022: Insights About
33+ Companies and 33+ Pipeline Drugs - ResearchAndMarkets.com
Camallergy is preparing its lead product, CA002 for the treatment of peanut allergy, for Phase III trials to support regulatory approval in...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.1M | 18 | -10% | $161M |
#2 | $3.5M | 18 | N/A | N/A |
#3 | $1.6M | 18 | N/A | N/A |
#4 | $2.5M | 18 | -14% | N/A |
#5 | $3.5M | 18 | -40% | N/A |